ALEXANDRIA, Va. The American Society of Clinical Oncology (ASCO) today highlighted five studies in a press briefing from among more than 4,500 abstracts publicly posted online at abstract.asco.org in advance of ASCO's 47th Annual Meeting.
Plenary, late-breaking and other major studies will be released in on-site press conferences at the Annual Meeting to be held June 1-5, 2012, at McCormick Place in Chicago, Ill. The meeting, which will feature the theme Collaborating to Conquer Cancer, is expected to draw approximately 30,000 cancer specialists from around the world.
"Nearly 50 years into the era of modern oncology, we can clearly see the fruits of our research investments," said Michael Link, MD, President of ASCO. "Findings to be presented at ASCO's Annual Meeting are part of the latest chapter in the history of progress against cancer. Today's studies demonstrate improvements in precision medicine that identify and exploit cancer's genetic weak spots to halt tumor growth and in some cases eradicate disease. Other studies give us valuable new tools and information to lessen the short- and long-term side effects of cancer treatment for our patients."
Studies highlighted in today's press briefing include:
'/>"/>
Contact: Susie Tappouni susie.tappouni@asco.org 571-483-1355 American Society of Clinical Oncology Source:Eurekalert |